Literature DB >> 17076860

Individual nucleic amplification technology does not prevent all hepatitis B virus transmission by blood transfusion.

Shoichi Inaba, Akira Ito, Yoshihisa Miyata, Hiroyuki Ishii, Shoko Kajimoto, Masatsugu Tanaka, Atsuo Maruta, Satoru Saito, Hisao Yugi, Minabu Hino, Kenji Tadokoro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17076860     DOI： 10.1111/j.1537-2995.2006.01011.x

Source DB:  PubMed          Journal:  Transfusion        ISSN： 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  9 in total

1.  Criteria for hepatitis B virus screening and validation of blood components in Italy: the position of the SIMTI HBV working group.

Authors:  Claudio Velati; Laura Fomiatti; Lorella Baruffi; Vanessa Piccinini; Daniele Prati; Anna Reina; Andrea Lobbiani; Alessandro Zanetti; Luisa Romanò
Journal:  Blood Transfus       Date:  2011-07-21       Impact factor: 3.443

Review 2.  Molecular virology in transfusion medicine laboratory.

Authors:  Daniel Candotti; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2012-12-21       Impact factor: 3.443

3.  Characterisation and follow-up study of occult hepatitis B virus infection in anti-HBc-positive qualified blood donors in southern China.

Authors:  Xianlin Ye; Tong Li; Xiaoxuan Xu; Peng Du; Jinfeng Zeng; Weigang Zhu; Baocheng Yang; Chengyao Li; Jean-Pierre Allain
Journal:  Blood Transfus       Date:  2016-05-17       Impact factor: 3.443

4.  Anti-hepatitis B core antigen testing with detection and characterization of occult hepatitis B virus by an in-house nucleic acid testing among blood donors in Behrampur, Ganjam, Orissa in southeastern India: implications for transfusion.

Authors:  Rajesh Panigrahi; Avik Biswas; Sibnarayan Datta; Arup Banerjee; Partha K Chandra; Pradip K Mahapatra; Bharat Patnaik; Sekhar Chakrabarti; Runu Chakravarty
Journal:  Virol J       Date:  2010-08-27       Impact factor: 4.099

5.  Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.

Authors:  Luisa Romanò; Claudio Velati; Giuseppe Cambiè; Laura Fomiatti; Claudio Galli; Alessandro Remo Zanetti
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

6.  Quantification of Transfusion Recipients at Risk of Receiving Hepatitis B Virus-Contaminated Blood Components: A Korean Study.

Authors:  Kunsei Lee; Hyeongsu Kim; Sounghoon Chang; Mina Hur; Vitna Kim; Hyoseon Jeong; Dong Hee Seo; SangWon Lee; Eun Jung Kim; Eunyoung Shin; Young Tack Kim
Journal:  Indian J Hematol Blood Transfus       Date:  2015-06-26       Impact factor: 0.900

7.  Occult hepatitis B virus infection among Egyptian blood donors.

Authors:  Zeinab N Said; Manal H El Sayed; Iman I Salama; Enas K Aboel-Magd; Magda H Mahmoud; Maged El Setouhy; Faten Mouftah; Manal B Azzab; Heidi Goubran; Amal Bassili; Gamal E Esmat
Journal:  World J Hepatol       Date:  2013-02-27

8.  Pre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity.

Authors:  Hyeongsu Kim; Mina Hur; Hee-Won Moon; Chul Min Park; Jin-Hee Cho; Kyoung Sik Park; Kunsei Lee; Sounghoon Chang
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

9.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.